Table 1.
Patient Characteristics
| Characteristics | All (n=33) | Group 1 (n=18) | Group 2 (n=15) | P-valuea |
|---|---|---|---|---|
| Age (yr) | 41±13 | 40±13 | 43±13 | 0.675 |
| Sex (male/female) | 15/18 | 10/8 | 5/10 | 0.296 |
| Disease duration (yr) | 9±9 | 7±6 | 12±11 | 0.174 |
| Period of tablet (day) | 53±10 | 55±6 | 52±13 | 0.342 |
| Period of granules (day) | 52±10 | 52±10 | 52±9 | 0.801 |
| Concomitant medications | ||||
| Steroids | 0 | 0 | 0 | - |
| Thiopurines | 11 | 7 | 4 | 0.458 |
| Anti-TNF-α antibodies | 6 | 3 | 3 | 0.804 |
| Topical medications | 5 | 3 | 2 | 0.790 |
| Steroid-dependent | 6 | 3 | 3 | 0.804 |
| Steroid-refractory | 3 | 2 | 1 | 0.698 |
| Partial Mayo score at enrollment | 1.0±1.4 | 1.2±1.6 | 0.8±1.1 | 0.405 |
Values are presented as mean±SD or number.
a
Group 1 vs. group 2.